Point-of-care testing

Intervention

2 papers2 findings

MeSH

  • 1 lab in 1 country
  • 1 finding against
  • Funder: Universität Potsdam
  • Humans1

Associations

1

Metabolic syndrome

no changein humans1upin humans1

1 study
  1. Point-of-care testing is associated with metabolic syndrome in humans (TRV 0.9-5.8%).

    “Risk factor classification and MetS diagnosis did not differ between measurement days.”

    Human trialn = 16

    Assessing the reliability and validity for metabolic syndrome diagnosis using point-of-care analyzers in a mobile setup - a pilot study

    BMC primary care19 Aug 2026

  2. Point-of-care testing predicts metabolic syndrome in humans.

    “A mobile setup using the Alere POC analyzer could be used as a valid mobile screening method for MetS”

    Human trialn = 50

    Assessing the reliability and validity for metabolic syndrome diagnosis using point-of-care analyzers in a mobile setup - a pilot study

    BMC primary care19 Aug 2026

More on Metabolic syndrome

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 2Sep 2026: 0Oct 2026: 02 in 12 months